Pazoo, Inc. (OTC: PZOO) is pleased to announce that MA & Associates LLC (DBA MA Analytics) testing laboratory in Las Vegas, Nevada recorded its first revenue from testing cannabis samples. The entire team of staff, management, and investors are extremely excited to be reporting that the testing lab is now generating revenue.
The lab is fully operational and can accept both recreational and medical cannabis samples for testing in Nevada. MA Analytics is currently working on expanding its footprint in the marketplace by establishing quality professional referral relationships with our vendors. Additionally, MA Analytics is reaching out to individual accounts and is speaking and presenting at an upcoming industry event later this week. The laboratory is continuing to ramp up operations and we anticipate that revenues will steadily increase.
Ben Hoehn, COO of Pazoo, Inc. said, “We are very excited to be able to report that MA & Associates has finally received its first revenues for the cannabis testing performed in its Las Vegas testing laboratory. We look forward to updating the public on additional revenue as the lab continues to ramp up.”
About Pazoo, Inc.
Pazoo, Inc. is focused on health, wellness and safety. Through our investment in MA & Associates LLC, in connection with recently opened lab, Pazoo will provide industry leading laboratory testing of cannabis. The lab will provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities.
Safe Harbor Statement
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
For Investor Relations:
UCS Advisors and Investor Relations, LLC